Neutral
Exagen (NASDAQ: XGN) director reports 7,500 restricted stock units
Exagen director Chas McKhann filed an amended Form 3, disclosing his direct ownership of 7,500 Restricted Stock Units (RSUs) as of July 17, 2025. This...